Bradley Croy Doak

Bradley Croy Doak

Auto-generated profile, based on publicly available information

Bradley Croy Doak

Monash University

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2014 in Chemistry & Biology
Verified
Journal Article
Closed access
BDBradley Croy Doak
Bradley Croy Doak
BOBjӧrn Over
Bjӧrn Over
FGFabrizio Giordanetto
Fabrizio Giordanetto
JKJan Kihlberg
Jan Kihlberg

30 October 2015 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
BDBradley C. Doak
Bradley C. Doak
JZJie Zheng
Jie Zheng
DDDoreen Dobritzsch
Doreen Dobritzsch
JKJan Kihlberg
Jan Kihlberg

1 June 2016 in Advanced Drug Delivery Reviews
Verified
Journal Article
Closed access
PMPär Matsson
Pär Matsson
BDBradley C. Doak
Bradley C. Doak
BOBjörn Over
Björn Over
JKJan Kihlberg
Jan Kihlberg

2 April 2018 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
MSMatteo Rossi Sebastiano
Matteo Rossi Sebastiano
BDBradley C. Doak
Bradley C. Doak
MBMaria Backlund
Maria Backlund
VPVasanthanathan Poongavanam
Vasanthanathan Poongavanam
BOBjörn Over
Björn Over
JKJan Kihlberg
Jan Kihlberg

17 October 2016 in Nature Chemical Biology
Verified
Journal Article
Closed access
BOBjörn Over
Björn Over
PMPär Matsson
Pär Matsson
CTChristian Tyrchan
Christian Tyrchan
PAPer Artursson
Per Artursson
BDBradley C Doak
Bradley C Doak
JKJan Kihlberg
Jan Kihlberg

8 December 2016 in Expert Opinion on Drug Discovery
Verified
Journal Article
Closed access
BDBradley C. Doak
Bradley C. Doak
JKJan Kihlberg
Jan Kihlberg
Targets that are ‘difficult-to-drug’ typically have binding sites that are large, highly lipophilic or polar, flexible, flat or featureless [1]. They contain few opportunities for high affinity int...